Are you experiencing any side effects with vascepa?

Why are patients asking about side effects from Vascepa?

Patients take Vascepa to lower triglycerides and reduce cardiovascular risk. They report bleeding events, joint pain, and gout flares as the most common complaints. Gout occurs because the drug raises uric acid levels, which can trigger joint inflammation.

What side effects are patients asking about most?

Gout flares head the list. Patients with prior gout history show a 1.5 times higher risk. Bleeding complications, especially nosebleeds and easy bruising, appear in 12 percent of users. Muscle pain and joint swelling rank next. Swelling in the legs also occurs.

What happens if you already have gout?

Vascepa increases uric acid production. This can spark new gout episodes or make existing ones worse. Doctors monitor uric acid levels before and after starting the drug. Patients already prone to gout may need alternative treatments.

How does Vascepa compare with other fish oil supplements?

Vascepa contains only EPA, the active ingredient. Regular fish oil supplements mix EPA and DHA. DHA raises LDL cholesterol, so Vascepa avoids that effect. Studies show Vascepa reduces cardiovascular events more reliably than mixed fish oil.

When does Vascepa's patent expire?

Vascepa's key patents expired in 2020. Generic versions entered the market afterward. Generic icosapent ethyl now costs far less than the brand. Pricing pressure continues from multiple manufacturers.

Who makes Vascepa?

Amarin Pharma developed and originally marketed Vascepa. Amarin still holds marketing rights in some regions. Generic manufacturers supply icosapent ethyl across the United States.